Dual AAV therapy ameliorates exercise-induced muscle injury and functional ischemia in murine models of duchenne muscular dystrophy

Human Molecular Genetics

Volumn 22, Issue 18, 2013, Pages 3720-3729

  Zhang, Yadong ^a,c   Yue, Yongping ^a   Li, Liang ^b   Hakim, Chady H ^a   Zhang, Keqing ^a   Thomas, Gail D ^b   Duan, Dongsheng ^a  

^a University of Missouri   (United States)

^b CEDARS SINAI MEDICAL CENTER   (United States)

^c CENTRAL HOSPITAL OF WUHAN   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DYSTROPHIN; NEURONAL NITRIC OXIDE SYNTHASE; PARVOVIRUS VECTOR; TYROSINE;

ADENO ASSOCIATED VIRUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; DUCHENNE MUSCULAR DYSTROPHY; ECCENTRIC MUSCLE CONTRACTION; ENZYME BINDING; GENE TRANSFER; HISTOPATHOLOGY; MOUSE; MUSCLE STRENGTH; NONHUMAN; PRIORITY JOURNAL; VASOCONSTRICTION; VIRAL GENE DELIVERY SYSTEM; VIRUS GENOME;

ANIMALS; DEPENDOVIRUS; DOGS; DYSTROPHIN; GENETIC THERAPY; GENETIC VECTORS; HUMANS; ISCHEMIA; MALE; MICE; MICE, TRANSGENIC; MUSCLE CONTRACTION; MUSCLE, SKELETAL; MUSCULAR DYSTROPHY, ANIMAL; MUSCULAR DYSTROPHY, DUCHENNE; NITRIC OXIDE SYNTHASE TYPE I; PHYSICAL CONDITIONING, ANIMAL; SARCOLEMMA;

EID: 84882936501     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddt224     Document Type: Article

References (42)

1. Kunkel, L.M. (2005) 2004 William Allan award address. Cloning of the DMD gene. Am. J. Hum. Genet., 76, 205-214.
2. Yue, Y., Ghosh, A., Long, C., Bostick, B., Smith, B.F., Kornegay, J.N. and Duan, D. (2008) A single intravenous injection of adeno-associated virus serotype-9 leads to whole body skeletal muscle transduction in dogs. Mol. Ther., 16, 1944-1952.
3. Bostick, B., Ghosh, A., Yue, Y., Long, C. and Duan, D. (2007) Systemic AAV-9 transduction in mice is influenced by animal age but not by the route of administration. Gene Ther., 14, 1605-1609.
4. Lai, Y., Yue, Y. and Duan, D. (2010) Evidence for the failure of adeno-associated virus serotype 5 to package a viral genome. or 1/4 8.2 kb. Mol. Ther., 18, 75-79.
5. England, S.B., Nicholson, L.V., Johnson, M.A., Forrest, S.M., Love, D.R., Zubrzycka-Gaarn, E.E., Bulman, D.E., Harris, J.B. and Davies, K.E. (1990) Very mild muscular dystrophy associated with the deletion of 46% of dystrophin. Nature, 343, 180-182.
6. Harper, S.Q., Hauser, M.A., DelloRusso, C., Duan, D., Crawford, R.W., Phelps, S.F., Harper, H.A., Robinson, A.S., Engelhardt, J.F., Brooks, S.V. et al. (2002) Modular flexibility of dystrophin: implications for gene therapy of Duchenne muscular dystrophy. Nat. Med., 8, 253-261.
7. Brenman, J.E., Chao, D.S., Xia, H., Aldape, K. and Bredt, D.S. (1995) Nitric oxide synthase complexed with dystrophin and absent from skeletal muscle sarcolemma in Duchenne muscular dystrophy. Cell, 82, 743-752.
8. Lai, Y., Thomas, G.D., Yue, Y., Yang, H.T., Li, D., Long, C., Judge, L., Bostick, B., Chamberlain, J.S., Terjung, R.L. et al. (2009) Dystrophins carrying spectrin-like repeats 16 and 17 anchornNOSto the sarcolemma and enhance exercise performance in a mouse model of muscular dystrophy. J. Clin. Invest., 119, 624-635.
9. Thomas, G.D. and Victor, R.G. (1998) Nitric oxide mediates contraction-induced attenuation of sympathetic vasoconstriction in rat skeletal muscle. J. Physiol., 506, 817-826.
10. Thomas, G.D., Sander, M., Lau, K.S., Huang, P.L., Stull, J.T. and Victor, R.G. (1998) Impaired metabolic modulation of alpha-adrenergic vasoconstriction in dystrophin-deficient skeletal muscle. Proc. Natl Acad. Sci. USA, 95, 15090-15095.
11. Sander, M., Chavoshan, B., Harris, S.A., Iannaccone, S.T., Stull, J.T., Thomas, G.D. and Victor, R.G. (2000) Functional muscle ischemia in neuronal nitric oxide synthase-deficient skeletal muscle of children with Duchenne muscular dystrophy. Proc. Natl Acad. Sci. USA, 97, 13818-13823.
12. Li, D., Yue, Y., Lai, Y., Hakim, C.H. and Duan, D. (2011) Nitrosative stress elicited by nNOSmu delocalization inhibits muscle force in dystrophin-null mice. J. Pathol., 223, 88-98.
13. Lai, Y., Yue, Y., Liu, M., Ghosh, A., Engelhardt, J.F., Chamberlain, J.S. and Duan, D. (2005) Efficient in vivo gene expression by trans-splicing adeno-associated viral vectors. Nat. Biotechnol., 23, 1435-1439.
14. Judge, L.M., Haraguchi, M. and Chamberlain, J.S. (2006) Dissecting the signaling and mechanical functions of the dystrophin-glycoprotein complex. J. Cell Sci., 119, 1537-1546.
15. Lai, Y., Zhao, J., Yue, Y. and Duan, D. (2013) alpha2 and alpha3 helices of dystrophin R16 and R17 frame a microdomain in the alpha1 helix of dystrophin R17 for neuronal NOS binding. Proc. Natl Acad. Sci. USA, 110, 525-530.
16. Zhang, Y. and Duan, D. (2012) Novel mini-dystrophin gene dual adeno-associated virus vectors restore neuronal nitric oxide synthase expression at the sarcolemma. Hum. Gene Ther., 23, 98-103.
17. Odom, G.L., Gregorevic, P., Allen, J.M. and Chamberlain, J.S. (2011) Gene therapy of mdx mice with large truncated dystrophins generated by recombination using rAAV6. Mol. Ther., 19, 36-45.
18. Li, D., Bareja, A., Judge, L., Yue, Y., Lai, Y., Fairclough, R., Davies, K.E., Chamberlain, J.S. and Duan, D. (2010) Sarcolemmal nNOS anchoring reveals a qualitative difference between dystrophin and utrophin. J. Cell Sci., 123, 2008-2013.
19. Pastoret, C. and Sebille, A. (1995)Mdxmice showprogressive weakness and muscle deterioration with age. J. Neurol. Sci., 129, 97-105.
20. Lynch, G.S., Hinkle, R.T., Chamberlain, J.S., Brooks, S.V. and Faulkner, J.A. (2001) Force and power output of fast and slow skeletal muscles from mdx mice 6-28 months old. J. Physiol., 535, 591-600.
21. Duan, D. (2011) Duchenne muscular dystrophy gene therapy: lost in translation? Res. Rep. Biol., 2, 31-42.
22. Hillier, B.J., Christopherson, K.S., Prehoda, K.E., Bredt, D.S. and Lim, W.A. (1999) Unexpected modes of PDZ domain scaffolding revealed by structure of nNOS-syntrophin complex. Science, 284, 812-815.
23. Wang, B., Li, J., Qiao, C., Chen, C., Hu, P., Zhu, X., Zhou, L., Bogan, J., Kornegay, J. and Xiao, X. (2008)A canine minidystrophin is functional and therapeutic in mdx mice. Gene Ther., 15, 1099-1106.
24. Yue, Y., Liu, M. and Duan, D. (2006) C-terminal truncated microdystrophin recruits dystrobrevin and syntrophin to the dystrophin-associated glycoprotein complex and reduces muscular dystrophy in symptomatic utrophin/dystrophin double knock-out mice. Mol. Ther., 14, 79-87.
25. Ghosh, A., Yue, Y. and Duan, D. (2011) Efficient transgene reconstitution with hybrid dual AAV vectors carrying the minimized bridging sequence. Hum. Gene Ther., 22, 77-83.
26. Ghosh, A., Yue, Y., Lai, Y. and Duan, D. (2008) A hybrid vector system expands aden-associated viral vector packaging capacity in a transgene independent manner. Mol. Ther., 16, 124-130.
27. Duan, D., Yue, Y. and Engelhardt, J.F. (2001) Expanding AAV packaging capacity with trans-splicing or overlapping vectors: a quantitative comparison. Mol. Ther., 4, 383-391.
28. Duan, D., Yue, Y., Yan, Z. and Engelhardt, J.F. (2000) A new dual-vector approach to enhance recombinant adeno-associated virus-mediated gene expression through intermolecular cis activation. Nat. Med., 6, 595-598.
29. Lai, Y., Yue, Y., Bostick, B. and Duan, D. (2010) In Duan, D. (ed.), Muscle Gene Therapy. Springer Science+Business Media, LLC, New York, pp. 205-218.
30. Ghosh, A. and Duan, D. (2007) Expending adeno-associated viral vector capacity: a tale of two vectors. Biotechnology and Genetic Engineering Reviews, 24, 165-177.
31. Lostal, W., Bartoli, M., Bourg, N., Roudaut, C., Bentaib, A., Miyake, K., Guerchet, N., Fougerousse, F., McNeil, P. and Richard, I. (2010) Efficient recovery of dysferlin deficiency by dual adeno-associated vector-mediated gene transfer. Hum. Mol. Genet., 19, 1897-1907.
32. Ghosh, A., Yue, Y., Shin, J.-H. and Duan, D. (2009) Systemic trans-splicing AAV delivery efficiently transduces the heart of adult mdx mouse, a model for Duchenne muscular dystrophy. Hum. Gene Ther., 20, 1319-1328.
33. Ghosh, A., Yue, Y., Long, C., Bostick, B. and Duan, D. (2007) Efficient whole-body transduction with trans-splicing adeno-associated viral vectors. Mol. Ther., 15, 750-755.
34. Ghosh, A., Yue, Y. and Duan, D. (2006) Viral serotype and the transgene sequence influence overlapping adeno-associated viral (AAV) vector-mediated gene transfer in skeletal muscle. J. Gene Med., 8, 298-305.
35. Chamberlain, J.S. (2002) Gene therapy of muscular dystrophy. Hum. Mol. Genet., 11, 2355-2362.
36. Chapman, V.M., Miller, D.R., Armstrong, D. and Caskey, C.T. (1989) Recovery of induced mutations for X chromosome-linked muscular dystrophy in mice. Proc. Natl Acad. Sci. USA, 86, 1292-1296.
37. Sicinski, P., Geng, Y., Ryder-Cook, A.S., Barnard, E.A., Darlison, M.G. and Barnard, P.J. (1989) The molecular basis of muscular dystrophy in the mdx mouse: a point mutation. Science, 244, 1578-1580.
38. Shin, J.H., Yue, Y. and Duan, D. (2012) Recombinant adeno-associated viral vector production and purification. Methods Mol. Biol., 798, 267-284.
39. Zhong, L., Li, B., Mah, C.S., Govindasamy, L., Agbandje-McKenna, M., Cooper, M., Herzog, R.W., Zolotukhin, I., Warrington, K.H. Jr., Weigel-Van Aken, K.A. et al. (2008) Next generation of adeno-associated virus 2 vectors: point mutations in tyrosines lead to high-efficiency transduction at lower doses. Proc. Natl Acad. Sci. USA, 105, 7827-7832.
40. Yue, Y., Li, Z., Harper, S.Q., Davisson, R.L., Chamberlain, J.S. and Duan, D. (2003) Microdystrophin gene therapy of cardiomyopathy restores dystrophin-glycoprotein complex and improves sarcolemma integrity in the mdx mouse heart. Circulation, 108, 1626-1632.
41. Hakim, C.H., Li, D. and Duan, D. (2011) Monitoring murine skeletal muscle function for muscle gene therapy. Methods Mol. Biol., 709, 75-89.
42. Hakim, C.H., Wasala, N.B. and Duan, D. (2013) Evaluation of muscle function of the extensor digitorum longus muscle ex vivo and tibialis anterio muscle in situ in mice. J. Vis. Exp., 73, e50183.